Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYBiomedicines

Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy—Part 2

  • Alfredo Mauriello1
  • Valeria Cetoretta2
  • Carmen Del Giudice3
  • Adriana Correra4
  • Anna Chiara Maratea5
  • Renato Gioia6
  • Biagio Liccardo7
  • Giovanni Esposito8
  • Vincenzo Russo7
  • Antonello D’Andrea6
8 affiliations
  1. 1S.C. Cardiology, Institute National Cancer, IRCCS, Fondazione “G. Pascale”, Via M. Semmola 52, 80131 Naples, Italy;
  2. 2Cardiology and Arrhythmology Clinic, Marche Polytechnic University, University Hospital “Ospedali Riuniti”, Via Conca 71, 60126 Ancona, Italy;
  3. 3Cardiology Unit, Boscotrecase Hospital, ASL NA3Sud, Via Lenza, 3, 80042 Boscotrecase, Italy;
  4. 4Cardiology Department, Ospedali Riuniti University Hospital, Viale Pinto 1, 71122 Foggia, Italy;
  5. 5Department of Cardiovascular Disease, ASL Napoli 1 Centro, Via Comunale del Principe, 13a, 80145 Napoli, Italy;
  6. 6Cardiology and Intensive Care Unit, Department of Cardiology, Umberto I Hospital, Via A. de Nicola 1, 84014 Nocera Inferiore, Italy;
  7. 7Cardiology Unit, Department of Medical and Translational Sciences, Monaldi Hospital, , Via L. Bianchi snc, 80131 Naples, Italy; (B.L.); (V.R.)
  8. 8Cardiology Unit, Department of Advanced Biomedical Sciences, , Via S. Pansini 5, 80131 Naples, Italy;
Read full textPDFCite

Related

  1. Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy—Part 1
    Alfredo Mauriello, Valeria Cetoretta, Carmen Del Giudice +7
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Cardiorenal Syndrome: Pathophysiology, Management, and the Challenge of Therapeutic Inertia
    Guido Gembillo, Vincenzo Calabrese, Luca Soraci +7
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. 1-Methylhistidine attenuates early myocardial inflammation in type 3 cardiorenal syndrome through modulation of the p105/p50 NF-κB axis
    Jiakun Zhang, Qian Wang, Xingyi Tu +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
  4. Association Between the Naples Prognostic Score and In-Hospital Mortality in Patients with Type 2 Cardiorenal Syndrome: A Retrospective Cohort Study
    Eren Eynel, Emre Eynel, Yusuf Can
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Association between the non-HDL-c to HDL-c ratio and mortality risk in cardiorenal syndrome : A population-based study from 1999 to 2018 NHANES
    Qiaoyun Ge, Hao Jiang, Hu Lu +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{mauriello2026cardiorenal,
  title = {{Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy—Part 2}},
  author = {Alfredo Mauriello and Valeria Cetoretta and Carmen Del Giudice and Adriana Correra and Anna Chiara Maratea and Renato Gioia and Biagio Liccardo and Giovanni Esposito and Vincenzo Russo and Antonello D’Andrea},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13701452},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Cardiorenal Syndrome: From Hemodynamic and Humoral Pathophysiology to New Frontiers in Modulation and Enabling Therapy—Part 2
AU  - Alfredo Mauriello
AU  - Valeria Cetoretta
AU  - Carmen Del Giudice
AU  - Adriana Correra
AU  - Anna Chiara Maratea
AU  - Renato Gioia
AU  - Biagio Liccardo
AU  - Giovanni Esposito
AU  - Vincenzo Russo
AU  - Antonello D’Andrea
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701452
SN  - 2227-9059
ER  -